ID: ALA128954

Max Phase: Preclinical

Molecular Formula: C19H25NO

Molecular Weight: 283.42

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C1CC2CCC1C(N1CCCCC1)C2c1ccccc1

Standard InChI:  InChI=1S/C19H25NO/c21-17-13-15-9-10-16(17)19(20-11-5-2-6-12-20)18(15)14-7-3-1-4-8-14/h1,3-4,7-8,15-16,18-19H,2,5-6,9-13H2

Standard InChI Key:  TWEOXNBABJCSDU-UHFFFAOYSA-N

Associated Targets(non-human)

Serotonin 2 (5-HT2) receptor 200 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Serotonin 1a (5-HT1a) receptor 193 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 283.42Molecular Weight (Monoisotopic): 283.1936AlogP: 3.62#Rotatable Bonds: 2
Polar Surface Area: 20.31Molecular Species: BASEHBA: 2HBD: 0
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.74CX LogP: 3.68CX LogD: 1.36
Aromatic Rings: 1Heavy Atoms: 21QED Weighted: 0.83Np Likeness Score: 0.69

References

1. Schlecht MF, Tsarouhtsis D, Lipovac MN, Debler EA..  (1990)  Synthesis and serotonin binding site studies of some conformationally restricted indolylethylamine analogues based on 2-amino-3-(3'-indolyl)bicyclo[2.2.2]octane.,  33  (1): [PMID:2136918] [10.1021/jm00163a062]

Source